glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Size:120 count Orally Active BRIGHTON COMPOUNDING PHARMACY -

Name: glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Size:120 count Orally Active BRIGHTON COMPOUNDING PHARMACY -
Brand: technospeak.fr
SKU: 36827122835
Price: 20.01 USD
Availability: InStock
Rating: 4.2628 (9 reviews)

SKU: 36827122835

Dispatch

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 29 - Nov 3

Description

glutathione small cell lung cancer Decreased biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small Size:120 count Orally Active BRIGHTON COMPOUNDING PHARMACY -

BRIGHTON COMPOUNDING PHARMACY - Updated August 2026 - 126 W Sego Lily Dr, Sandy, Utah - Pharmacy - Phone Number - Yelp

Dornberger K, Bockel V, Heyer J, Schonfeld CL, Tonew M, Tonew E

Orally Active

Size:120 count

PLoS One 12, e0186802 (2017), 10.1371/journal.pone.0186802

Exchange/Return Notes